Functionally informed fine-mapping and polygenic localization of complex trait heritability.
- Authors
- Weissbrod, Omer; Hormozdiari, Farhad; Benner, Christian; Cui, Ran; Ulirsch, Jacob; Gazal, Steven; Schoech, Armin P; van de Geijn, Bryce; Reshef, Yakir; MΓ‘rquez-Luna, Carla; O'Connor, Luke; Pirinen, Matti; Finucane, Hilary K; Price, Alkes L
- Year
- 2020
- Journal
- Nature genetics
- PMID
- 33199916
- DOI
- 10.1038/s41588-020-00735-5
- PMCID
- PMC7710571
Fine-mapping aims to identify causal variants impacting complex traits. We propose PolyFun, a computationally scalable framework to improve fine-mapping accuracy by leveraging functional annotations across the entire genome-not just genome-wide-significant loci-to specify prior probabilities for fine-mapping methods such as SuSiE or FINEMAP. In simulations, PolyFunβ+βSuSiE and PolyFunβ+βFINEMAP were well calibrated and identified >20% more variants with a posterior causal probability >0.95 than identified in their nonfunctionally informed counterparts. In analyses of 49 UK Biobank traits (average nβ=β318,000), PolyFunβ+βSuSiE identified 3,025 fine-mapped variant-trait pairs with posterior causal probability >0.95, a >32% improvement versus SuSiE. We used posterior mean per-SNP heritabilities from PolyFunβ+βSuSiE to perform polygenic localization, constructing minimal sets of common SNPs causally explaining 50% of common SNP heritability; these sets ranged in size from 28 (hair color) to 3,400 (height) to 2 million (number of children). In conclusion, PolyFun prioritizes variants for functional follow-up and provides insights into complex trait architectures.
Calibration, power and computational cost of fine-mapping methods in main simulations.(a-b) FDR at PIP=0.95 (a) and PIP=0.5 (b). Upper dashed horizontal lines denote conservative FDR estimates. Lower dotted horizontal lines denote anti-conservative FDR estimates, which are not recommended (Supplementary Note). (c-d) Power at PIP=0.95 (c) and PIP=0.5 (d). The first bar of each method uses non-functionally informed fine-mapping (denoted β), and the second uses functionally informed fine-mapping (denoted +). (e) The average runtime required to fine-map a 3Mb locus in a genome-wide analysis (log scale). The first bar of each method uses non-functionally informed fine-mapping (denoted β), and the second uses functionally informed fine-mapping (denoted +). (f) The total runtime required to fine-map different numbers of loci, for functionally informed fine-mapping methods only (log scale). The runtimes of PolyFun + SuSiE and PolyFun + FINEMAP are sub-linear because they include the fixed preprocessing cost of computing prior causal probabilities (630 minutes). Error bars denote standard errors. Numerical results, including results for CAVIARBF2β and CAVIARBF2, and including panel (f) results for non-functionally informed methods, are reported in Supplementary Table 4.
Assessing the individual impact of step 5 of PolyFun (specifying prior causal probabilities in proportion of the re-estimated per-SNP heritabilities) via perturbation analysis, by randomly permuting estimated prior causal probabilities.The figure is similar to Extended Data Figure 1 but applies a different perturbation (randomly permuting estimated prior causal probabilities). Numerical reports are provided in Supplementary Table 6.
Visualization of fine-mapping results for UK Biobank traits.We display an ideogram of all 2,225 PIP>0.95 fine-mapped SNPs identified by PolyFun + SuSiE across 49 UK Biobank traits. Traits are color-coded into groups (see legend and Supplementary Table 8). White circles indicate SNPs that are pleiotropic for β₯2 genetically uncorrelated traits, with circles to the right of a white circle denoting the genetically uncorrelated traits (max of 5 colored circles due to space limitations). Numerical results are reported in Supplementary Table 10.
Functional enrichment of PolyFun + SuSiE fine-mapped common SNPs for UK Biobank traits.The figure is analogous to Figure 4 but uses PIPs computed by PolyFun + SuSiE instead of SuSiE. Numerical results are reported in Supplementary Table 26.
Functional enrichment of SuSiE fine-mapped MAF>0.001 SNPs for UK Biobank traits.The figure is analogous to Figure 4 but uses MAF>0.001 SNPs instead of common (MAF>0.05) SNPs. Numerical results are reported in Supplementary Table 27.
Functional enrichment of SuSiE fine-mapped low-frequency and rare SNPs for UK Biobank traits.The figure is analogous to Figure 4 but uses only low-frequency and rare SNPs (0.05>MAF>0.001) instead of common (MAF>0.05) SNPs. Numerical results are reported in Supplementary Table 28.
Summary of fine-mapping results for UK Biobank traits.(a) the number of SNPs with PIP>0.95 identified by SuSiE (black bars) and PolyFun + SuSiE (gray bars) across 16 genetically uncorrelated traits in the UK Biobank. Traits are ordered by PolyFun + SuSiE results. The numbers in the legend refer to the sum of all 49 traits analyzed. (b) The proportion of MAF>0.001 SNP-heritability (hg2) tagged by lead GWAS SNPs (gray bars) and by PolyFun + SuSiE PIP>0.95 SNPs (black bars). Traits are ordered as in panel (a). For hair color, the hg2 tagged by PIP>0.95 SNPs is greater than hg2 tagged by lead GWAS SNPs. MPV: Mean platelet volume; BMD: bone mineral density; MCH: mean corpuscular hemoglobin; MC: monocyte count; HLSRC: high light scatter reticulocyte count; FEV1/FVC: ratio of forced expiratory volume to forced vital capacity; DBP: diastolic blood pressure; FVC: forced vital capacity. Numerical results are reported in Supplementary Tables 9,14.
Examples of the advantages of functionally-informed fine-mapping for UK Biobank traits.We report four examples where PolyFun + SuSiE identified a fine-mapped common SNP (PIP>0.95) but SuSiE did not (PIP<0.5 for all SNPs within 1Mb). Circles denote PolyFun + SuSiE PIPs and squares denote SuSiE PIPs. SNPs are shaded according to their prior causal probabilities as estimated by PolyFun. The top PolyFun + SuSiE SNP is labeled (next to its PolyFun + SuSiE PIP and its SuSiE PIP). The annotation of each top PolyFun + SuSiE SNP that is most enriched among SuSiE PIP>0.95 SNPs (Methods) is reported in parentheses below its label. Asterisks denote lead GWAS SNPs. Numerical results are reported in Supplementary Table 16.
Functional enrichment of SuSiE fine-mapped common SNPs for UK Biobank traits.We report the functional enrichment of fine-mapped common SNPs (defined as the proportion of common SNPs in a PIP range lying in an annotation divided by the proportion of genome-wide common SNPs lying in the annotation) for 5 selected binary annotations, meta-analyzed across 14 genetically uncorrelated UK Biobank traits with β₯10 PIP>0.95 SNPs (log scale). The proportion of common SNPs lying in each binary annotation is reported above its name. The horizontal dashed line denotes no enrichment. Error bars denote standard errors. Numerical results for all 50 main binary annotations and all traits are reported in Supplementary Table 17.
Polygenic localization results for UK Biobank traits.(a) M50% estimates across 16 genetically uncorrelated traits. For each trait, we report the number of top-ranked common SNPs (using PolyFun + SuSiE posterior per-SNP heritability estimates for ranking) causally explaining 50% of common SNP heritability, and its standard error (log scale). The horizontal dashed line denotes the total number of common SNPs in the analysis (7.0 million). (b-d) The proportion of common SNP heritability of (b) hair color, (c) height, and (d) number of children explained by different numbers of top-ranked SNPs, for all 7.0 million common SNPs (left) and the 5,000 top-ranked common (right). Gray shading denotes standard errors. Dashed black lines denote a null model with a constant per-SNP heritability. We also report the number of top-ranked SNPs causally explaining 50% of common SNP heritability, denoted M50%. Discontinuities in the slope indicate transitions between SNP bins. Numerical results for all 49 UK Biobank traits are reported in Supplementary Table 31.
Assessing the individual impact of step 1 of PolyFun (estimating functional enrichment) via perturbation analysis, by randomly shuffling different proportions of annotation coefficient estimates.For each evaluated value of the proportion of shuffled annotation coefficient estimates, we report the number of experiments having each obtained FDR level >0 (left panel) and the number of experiments having each obtained power level >0 (right panel), out of 1000 experiments. FDR and power are reported with respect to identifying PIPβ₯0.95 SNPs. Experiments with FDR=0 (resp. power=0) are not reported in the left panel (resp. right panel) to improve clarity. Numerical reports are provided in Supplementary Table 6.
Assessing the individual impact of step 2 of PolyFun (estimating per-SNP heritabilities on odd/even chromosomes) via perturbation analysis, by using both odd and even chromosomes to estimate functional enrichment.The figure is similar to Extended Data Figure 1 but applies a different perturbation (using both odd and even chromosomes to estimate functional enrichment). Numerical reports are provided in Supplementary Table 6.
Assessing the individual impact of step 3 of PolyFun (partitioning all SNPs into 20 bins of similar per-SNP heritability) via perturbation analysis, by varying the number of per-SNP heritability bins.The figure is similar to Extended Data Figure 1 but applies a different perturbation (changing the number of per-SNP heritability bins). Numerical reports are provided in Supplementary Table 6.
Assessing the individual impact of step 4 of PolyFun (re-estimating per-SNP heritabilities within each bin excluding the target chromosome) via perturbation analysis, by not excluding the target chromosome from the re-estimation procedure.The figure is similar to Extended Data Figure 1 but applies a different perturbation (disables the exclusion of the target chromosome, either when using the default sample size N=320K or when using a smaller sample size of N=10K). Numerical reports are provided in Supplementary Table 6.
| Name | Type |
|---|---|
| 337K dataset local | cohort |
| another selected trait local | phenotype |
| autoimmune diseases | phenotype |
| baseline-LF 2.2.UKB model local | drug |
| baseline-LF model local | drug |
| biochemical trait local | phenotype |
| blood cell traits local | phenotype |
| blood traits local | phenotype |
| British-ancestry individuals local | cohort |
| British ancestry samples local | cohort |
| British-ancestry UK Biobank samples local | cohort |
| causal SNP | cohort |
| chronotype | phenotype |
| common SNP heritability local | phenotype |
| complex traits | phenotype |
| conserved regions local | phenotype |
| European-ancestry UK Biobank samples local | cohort |
| FINEMAP | drug |
| fine-mapped SNPs local | variant |
| GCTA-COJO | drug |
| genetically uncorrelated traits local | phenotype |
| genome-wide significant SNP local | variant |
| GWAS target sample local | cohort |
| H3K4me3 | drug |
| hair color local | phenotype |
| height | phenotype |
| L2 regularization local | drug |
| large-effect SNPs local | variant |
| LD reference panel local | cohort |
| LD reference panel local | drug |
| lead GWAS SNPs local | variant |
| low-frequency SNPs local | variant |
| luciferase | drug |
| M50% local | phenotype |
| M50%* local | phenotype |
| MAF>0.001 local | variant |
| metabolic traits | phenotype |
| non-British UK Biobank individuals local | cohort |
| non-synonymous SNP | variant |
| number of children | phenotype |
| other cohorts or consortia local | cohort |
| per-SNP heritability estimation local | phenotype |
| phenotype | phenotype |
| pigmentation traits local | phenotype |
| PIP>0.95 fine-mapped SNPs local | variant |
| PIP>0.95 SNP local | variant |
| PIP>0.95 SNPs local | variant |
| PolyFun | drug |
| PolyFun dataset local | cohort |
| PolyLoc local | drug |
| PolyLoc dataset local | cohort |
| promoter-ExAC local | drug |
| rare variant | cohort |
| repressed regions local | drug |
| samples | cohort |
| selected trait local | phenotype |
| simulated traits local | phenotype |
| S-LDSC local | drug |
| SNP | cohort |
| standardized phenotypes y local | phenotype |
| summary LD information local | drug |
| SuSiE | drug |
| SuSiE N=107K analysis local | cohort |
| trait | phenotype |
| UK10K cohort local | cohort |
| UKB | cohort |
| UK Biobank | cohort |
| UK Biobank traits local | phenotype |
| well-imputed SNPs local | variant |
No uploaded files.
| Citation | PMID | DOI | Status |
|---|---|---|---|
| BennerC FINEMAP: efficient variable selection using summary data from genome-wide association studies. Bioinformatics 32, 1493β1501 (2016).2677313110.1093/bioinformatics/btw018PMC4866522 | β | β | β |
| BennerC Prospects of Fine-Mapping Trait-Associated Genomic Regions by Using Summary Statistics from Genome-wide Association Studies. Am. J. Hum. Genet. 101, 539β551 (2017).2894296310.1016/j.ajhg.2017.08.012PMC5630179 | β | β | β |
| BennerC, HavulinnaA, SalomaaV, RipattiS & PirinenM Refining fine-mapping: effect sizes and regional heritability. bioRxiv 318618 (2018). | β | β | β |
| BoyleEA, LiYI & PritchardJK An Expanded View of Complex Traits: From Polygenic to Omnigenic. Cell 169, 1177β1186 (2017).2862250510.1016/j.cell.2017.05.038PMC5536862 | β | β | β |
| BycroftC The UK Biobank resource with deep phenotyping and genomic data. Nature 562, 203 (2018).3030574310.1038/s41586-018-0579-zPMC6786975 | β | β | β |
| ChatterjeeN, ShiJ & GarcΓa-ClosasM Developing and evaluating polygenic risk prediction models for stratified disease prevention. Nat. Rev. Genet. 17, 392β406 (2016).2714028310.1038/nrg.2016.27PMC6021129 | β | β | β |
| ChenW Fine mapping causal variants with an approximate Bayesian method using marginal test statistics. Genetics 200, 719β736 (2015).2594856410.1534/genetics.115.176107PMC4512539 | β | β | β |
| ChenW, McDonnellSK, ThibodeauSN, TillmansLS & SchaidDJ Incorporating functional annotations for fine-mapping causal variants in a Bayesian framework using summary statistics. Genetics 204, 933β958 (2016).2765594610.1534/genetics.116.188953PMC5105870 | β | β | β |
| ClaussnitzerM FTO obesity variant circuitry and adipocyte browning in humans. N. Engl. J. Med. 373, 895β907 (2015).2628774610.1056/NEJMoa1502214PMC4959911 | β | β | β |
| De LeeuwCA, NealeBM, HeskesT & PosthumaD The statistical properties of gene-set analysis. Nat. Rev. Genet. 17, 353 (2016).2707086310.1038/nrg.2016.29 | β | β | β |
| FarhKK-H Genetic and epigenetic fine mapping of causal autoimmune disease variants. Nature 518, 337 (2015).2536377910.1038/nature13835PMC4336207 | β | β | β |
| FinucaneHK Partitioning heritability by functional annotation using genome-wide association summary statistics. Nat. Genet. 47, 1228β1235 (2015).2641467810.1038/ng.3404PMC4626285 | β | β | β |
| GazalS Functional architecture of low-frequency variants highlights strength of negative selection across coding and non-coding annotations. Nat. Genet. 50, 1600β1607 (2018).3029796610.1038/s41588-018-0231-8PMC6236676 | β | β | β |
| GazalS Linkage disequilibriumβdependent architecture of human complex traits shows action of negative selection. Nat. Genet. 49, 1421β1427 (2017).2889206110.1038/ng.3954PMC6133304 | β | β | β |
| GazalS, Marquez-LunaC, FinucaneHK & PriceAL Reconciling S-LDSC and LDAK functional enrichment estimates. Nat. Genet. 51, 1202β1204 (2019).3128557910.1038/s41588-019-0464-1PMC7006477 | β | β | β |
| HaworthS Apparent latent structure within the UK Biobank sample has implications for epidemiological analysis. Nat. Commun. 10, 333 (2019).3065917810.1038/s41467-018-08219-1PMC6338768 | β | β | β |
| HormozdiariF, KostemE, KangEY, PasaniucB & EskinE Identifying causal variants at loci with multiple signals of association. Genetics 198, 497β508 (2014).2510451510.1534/genetics.114.167908PMC4196608 | β | β | β |
| HuangH Fine-mapping inflammatory bowel disease loci to single-variant resolution. Nature 547, 173β178 (2017).2865820910.1038/nature22969PMC5511510 | β | β | β |
| HujoelML, GazalS, HormozdiariF, van de GeijnB & PriceAL Disease heritability enrichment of regulatory elements is concentrated in elements with ancient sequence age and conserved function across species. Am. J. Hum. Genet. 104, 611β624 (2019).3090539610.1016/j.ajhg.2019.02.008PMC6451699 | β | β | β |
| JungI A compendium of promoter-centered long-range chromatin interactions in the human genome. Nat. Genet. 1β8 (2019).3150151710.1038/s41588-019-0494-8PMC6778519 | β | β | β |
| KichaevG & PasaniucB Leveraging functional-annotation data in trans-ethnic fine-mapping studies. Am. J. Hum. Genet. 97, 260β271 (2015).2618981910.1016/j.ajhg.2015.06.007PMC4573268 | β | β | β |
| KichaevG Improved methods for multi-trait fine mapping of pleiotropic risk loci. Bioinformatics 33, 248β255 (2017).2766350110.1093/bioinformatics/btw615PMC5254076 | β | β | β |
| KichaevG Integrating Functional Data to Prioritize Causal Variants in Statistical Fine-Mapping Studies. PLoS Genet. 10, e1004722 (2014).2535720410.1371/journal.pgen.1004722PMC4214605 | β | β | β |
| LandiMT Genome-wide association meta-analyses combining multiple risk phenotypes provide insights into the genetic architecture of cutaneous melanoma susceptibility. Nat. Genet. 52, 494β504 (2020).3234152710.1038/s41588-020-0611-8PMC7255059 | β | β | β |
| LohP-R Contrasting genetic architectures of schizophrenia and other complex diseases using fast variance-components analysis. Nat. Genet. 47, 1385β1392 (2015).2652377510.1038/ng.3431PMC4666835 | β | β | β |
| LohP-R, KichaevG, GazalS, SchoechAP & PriceAL Mixed-model association for biobank-scale datasets. Nat. Genet. 50, 906β908 (2018).2989201310.1038/s41588-018-0144-6PMC6309610 | β | β | β |
| MahajanA Fine-mapping type 2 diabetes loci to single-variant resolution using high-density imputation and islet-specific epigenome maps. Nat. Genet. 50, 1505 (2018).3029796910.1038/s41588-018-0241-6PMC6287706 | β | β | β |
| MahajanA Refining the accuracy of validated target identification through coding variant fine-mapping in type 2 diabetes. Nat. Genet. 50, 559 (2018).2963238210.1038/s41588-018-0084-1PMC5898373 | β | β | β |
| Marquez-LunaC Modeling functional enrichment improves polygenic prediction accuracy in UK Biobank and 23andMe data sets. bioRxiv 375337 (2018).10.1038/s41467-021-25171-9PMC852370934663819 | β | β | β |
| MartinAR Clinical use of current polygenic risk scores may exacerbate health disparities. Nat. Genet. 51, 584 (2019).3092696610.1038/s41588-019-0379-xPMC6563838 | β | β | β |
| MauranoMT Systematic Localization of Common Disease-Associated Variation in Regulatory DNA. Science 337, 1190β1195 (2012).2295582810.1126/science.1222794PMC3771521 | β | β | β |
| MoserG Simultaneous discovery, estimation and prediction analysis of complex traits using a Bayesian mixture model. PLoS Genet 11, e1004969 (2015).2584966510.1371/journal.pgen.1004969PMC4388571 | β | β | β |
| MΓ‘rquez-LunaC, LohP-R, Consortium, S. A. T. 2 D. (SAT2D), Consortium, S. T. 2 D. & Price, A. L. Multiethnic polygenic risk scores improve risk prediction in diverse populations. Genet. Epidemiol. 41, 811β823 (2017).2911033010.1002/gepi.22083PMC5726434 | β | β | β |
| OβConnorLJ Extreme Polygenicity of Complex Traits Is Explained by Negative Selection. Am. J. Hum. Genet. 105, 456β476 (2019).3140209110.1016/j.ajhg.2019.07.003PMC6732528 | β | β | β |
| PasaniucB & PriceAL Dissecting the genetics of complex traits using summary association statistics. Nat. Rev. Genet. 18, 117β127 (2017).2784042810.1038/nrg.2016.142PMC5449190 | β | β | β |
| PickrellJK Detection and interpretation of shared genetic influences on 42 human traits. Nat. Genet. 48, 709 (2016).2718296510.1038/ng.3570PMC5207801 | β | β | β |
| PriceAL Long-range LD can confound genome scans in admixed populations. Am. J. Hum. Genet. 83, 132β135 (2008).1860630610.1016/j.ajhg.2008.06.005PMC2443852 | β | β | β |
| PurcellSM Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 460, 748β752 (2009).1957181110.1038/nature08185PMC3912837 | β | β | β |
| SchaidDJ, ChenW & LarsonNB From genome-wide associations to candidate causal variants by statistical fine-mapping. Nat Rev Genet 19, 491β504 (2018).2984461510.1038/s41576-018-0016-zPMC6050137 | β | β | β |
| ShendureJ, FindlayGM & SnyderMW Genomic medicineβprogress, pitfalls, and promise. Cell 177, 45β57 (2019).3090154710.1016/j.cell.2019.02.003PMC6531313 | β | β | β |
| ShiH, KichaevG & PasaniucB Contrasting the Genetic Architecture of 30 Complex Traits from Summary Association Data. Am. J. Hum. Genet. 99, 139β53 (2016).2734668810.1016/j.ajhg.2016.05.013PMC5005444 | β | β | β |
| SolovieffN, CotsapasC, LeePH, PurcellSM & SmollerJW Pleiotropy in complex traits: challenges and strategies. Nat. Rev. Genet. 14, 483 (2013).2375279710.1038/nrg3461PMC4104202 | β | β | β |
| The ENCODE Project Consortium. An integrated encyclopedia of DNA elements in the human genome. Nature 489, 57β74 (2012).2295561610.1038/nature11247PMC3439153 | β | β | β |
| The Roadmap Epigenomics Consortium. Integrative analysis of 111 reference human epigenomes. Nature 518, 317β330 (2015).2569356310.1038/nature14248PMC4530010 | β | β | β |
| The UK10K Consortium The UK10K project identifies rare variants in health and disease. Nature 526, 82 (2015).2636779710.1038/nature14962PMC4773891 | β | β | β |
| The Wellcome Trust Case Control Consortium Bayesian refinement of association signals for 14 loci in 3 common diseases. Nat. Genet. 44, 1294β1301 (2012).2310400810.1038/ng.2435PMC3791416 | β | β | β |
| TrynkaG Chromatin marks identify critical cell types for fine mapping complex trait variants. Nat. Genet. 45, 124 (2013).2326348810.1038/ng.2504PMC3826950 | β | β | β |
| UlirschJC Interrogation of human hematopoiesis at single-cell and single-variant resolution. Nat. Genet. (2019) doi:10.1038/s41588-019-0362-6.PMC644138930858613 | β | β | β |
| VisscherPM 10 years of GWAS discovery: biology, function, and translation. Am. J. Hum. Genet. 101, 5β22 (2017).2868685610.1016/j.ajhg.2017.06.005PMC5501872 | β | β | β |
| VujkovicM Discovery of 318 new risk loci for type 2 diabetes and related vascular outcomes among 1.4 million participants in a multi-ancestry meta-analysis. Nat. Genet. 1β12 (2020).3254192510.1038/s41588-020-0637-yPMC7343592 | β | β | β |
| WangG, SarkarA, CarbonettoP & StephensM A simple new approach to variable selection in regression, with application to genetic fine mapping. J. R. Stat. Soc. Ser. B Stat. Methodol. n/a, (2020).10.1111/rssb.12388PMC1020194837220626 | β | β | β |
| WangH & SongM Ckmeans.1d.dp: Optimal k-means Clustering in One Dimension by Dynamic Programming. R J 3, 29β33 (2011).27942416PMC5148156 | β | β | β |
| WangK, LiM & HakonarsonH Analysing biological pathways in genome-wide association studies. Nat. Rev. Genet. 11, 843 (2010).2108520310.1038/nrg2884 | β | β | β |
| WelterD The NHGRI GWAS Catalog, a curated resource of SNP-trait associations. Nucleic Acids Res 42, D1001βD1006 (2014).2431657710.1093/nar/gkt1229PMC3965119 | β | β | β |
| WestraH-J Fine-mapping and functional studies highlight potential causal variants for rheumatoid arthritis and type 1 diabetes. Nat. Genet. 50, 1366β1374 (2018).3022464910.1038/s41588-018-0216-7PMC6364548 | β | β | β |
| WolfeD, DudekS, RitchieMD & PendergrassSA Visualizing genomic information across chromosomes with PhenoGram. BioData Min. 6, 18 (2013).2413173510.1186/1756-0381-6-18PMC4015356 | β | β | β |
| WuttkeM A catalog of genetic loci associated with kidney function from analyses of a million individuals. Nat. Genet. 51, 957 (2019).3115216310.1038/s41588-019-0407-xPMC6698888 | β | β | β |
| YangJ Common SNPs explain a large proportion of the heritability for human height. Nat. Genet. 42, 565β569 (2010).2056287510.1038/ng.608PMC3232052 | β | β | β |
| YangJ Conditional and joint multiple-SNP analysis of GWAS summary statistics identifies additional variants influencing complex traits. Nat. Genet. 44, 369 (2012).2242631010.1038/ng.2213PMC3593158 | β | β | β |
| YangJ Genetic variance estimation with imputed variants finds negligible missing heritability for human height and body mass index. Nat. Genet. 47, 1114β20 (2015).2632305910.1038/ng.3390PMC4589513 | β | β | β |
| ZegginiE, GloynAL, BartonAC & WainLV Translational genomics and precision medicine: Moving from the lab to the clinic. Science 365, 1409β1413 (2019).3160426810.1126/science.aax4588 | β | β | β |
| ZengJ Signatures of negative selection in the genetic architecture of human complex traits. Nat. Genet. 50, 746 (2018).2966216610.1038/s41588-018-0101-4 | β | β | β |
| ZhangY, QiG, ParkJ-H & ChatterjeeN Estimation of complex effect-size distributions using summary-level statistics from genome-wide association studies across 32 complex traits. Nat. Genet. 50, 1318 (2018).3010476010.1038/s41588-018-0193-x | β | β | β |
| ZhuX & StephensM Large-scale genome-wide enrichment analyses identify new trait-associated genes and pathways across 31 human phenotypes. Nat. Commun. 9, 4361 (2018).3034129710.1038/s41467-018-06805-xPMC6195536 | β | β | β |
In this knowledge base
| Title | Year | PMID |
|---|---|---|
| Gene-based polygenic risk scores analysis of alcohol use disorder in African Americans. | 2022 | 35790736 |
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| cellSTAAR: incorporating single-cell-sequencing-based functional data to boost power in rare variant association testing of noncoding regions. | Van Buren E et al. | β | 2026 | β |
| Clinical use of polygenic risk scores: current status, barriers and future directions. | Kullo IJ | β | 2026 | β |
| Combining functional annotation and multi-trait fine-mapping methods improves fine-mapping resolution at glycaemic trait loci. | Soenksen J et al. | β | 2026 | β |
| Cross-Ancestry Polygenic Prediction: Comparing Methods and Assessing Transferability Across Traits. | Momin MM et al. | β | 2026 | β |
| Decoding the triglyceride-glucose index in metabolic dysfunction-associated steatotic liver disease: integrative insights from Mendelian randomization, cross-tissue transcriptomics, and spatial multi-omics. | Wei S et al. | β | 2026 | β |
| Disturbances of paraventricular thalamic nucleus neurons in bipolar disorder revealed by single-nucleus analysis. | Nishioka M et al. | β | 2026 | β |
| Fast and flexible joint fine-mapping of multiple traits via the Sum of Single Effects model. | Zou Y et al. | β | 2026 | β |
| Functional dissection of complex trait variants at single-nucleotide resolution. | Siraj L et al. | β | 2026 | β |
| Genome-wide fine-mapping improves identification of causal variants. | Wu Y et al. | β | 2026 | β |
| Identifying drug targets for schizophrenia through gene prioritization. | Kraft J et al. | β | 2026 | β |
| Inherited resilience to clonal hematopoiesis by modifying stem cell RNA regulation. | Agarwal G et al. | β | 2026 | β |
| Large-scale integration of omics and electronic health records to identify potential risk protein biomarkers and therapeutic drugs for cancer prevention. | Li Q et al. | β | 2026 | β |
| Multi-ancestry genome-wide association analyses of refractive error augment genetic discovery and polygenic prediction. | Cheng FF et al. | β | 2026 | β |
| MultiSuSiE improves multi-ancestry fine-mapping in All of Us whole-genome sequencing data. | Rossen J et al. | β | 2026 | β |
| On ARGs, pedigrees, and genetic relatedness matrices. | Lehmann B et al. | β | 2026 | β |
| Parameter-efficient fine-tuning enables scalable transfer of regulatory sequence models to novel contexts. | Yuan H et al. | β | 2026 | β |
| Simplifying causal gene identification in GWAS loci. | Schipper M et al. | β | 2026 | β |
| Single-cell polygenic risk scores dissect cellular and molecular heterogeneity of complex human diseases. | Zhang S et al. | β | 2026 | β |
| The brain neurovascular epigenome and its association with dementia. | Ziegler KC et al. | β | 2026 | β |
| Trans-ancestry genome-wide analyses of bipolar disorder in East Asian and European populations improve genetic discovery. | Zhang CY et al. | β | 2026 | β |
| A contextual genomic perspective on physical activity and its relationship to health, well being and illness. | Galimberti M et al. | β | 2025 | β |
| A DNA language model based on multispecies alignment predicts the effects of genome-wide variants. | Benegas G et al. | β | 2025 | β |
| An ancient regulatory variant of ACSF3 influences the coevolution of increased human height and basal metabolic rate via metabolic homeostasis. | Zhang Y et al. | β | 2025 | β |
| An evolving understanding of multiple causal variants underlying genetic association signals. | Long E et al. | β | 2025 | β |
| BTS: a scalable Bayesian Tissue Score for prioritizing GWAS variants and their functional contexts across >1000s of omics datasets. | Kuksa PP et al. | β | 2025 | β |
| Can classical statistics and deep learning converge on explainable, causally driven target discovery? | Chen L | β | 2025 | β |
| CAUSALdb2: an updated database for causal variants of complex traits. | Wang J et al. | β | 2025 | β |
| Characterization of non-coding variants associated with transcription-factor binding through ATAC-seq-defined footprint QTLs in liver. | Dudek MF et al. | β | 2025 | β |
| Clinical validation of an integrated risk assessment test incorporating genomic and non-genomic data for sporadic breast cancer in Colombia. | Velasco Parra HM et al. | β | 2025 | β |
| Clustering of lymphoid neoplasms by cell of origin, somatic mutation and drug usage profiles: a multi-trait genome-wide association study. | GΓΌler M et al. | β | 2025 | β |
| Deciphering genetic susceptibility to clear cell renal cell carcinoma. | Mandelia M et al. | β | 2025 | β |
| Efficient blockLASSO for polygenic scores with applications to all of us and UK Biobank. | Raben TG et al. | β | 2025 | β |
| FINEMAP-miss: fine-mapping genome-wide association studies with missing genotype information. | Kartau J et al. | β | 2025 | β |
| Fine-mapping causal tissues and genes at disease-associated loci. | Strober BJ et al. | β | 2025 | β |
| Fine-mapping genomic loci refines bipolar disorder risk genes. | Koromina M et al. | β | 2025 | β |
| Fine-mapping methods for complex traits: essential adaptations for samples of related individuals. | Wang J et al. | β | 2025 | β |
| Genetic and neural mechanisms shared by schizophrenia and depression. | Xie Y et al. | β | 2025 | β |
| Genome-wide analysis of brain age identifies 59 associated loci and unveils relationships with mental and physical health. | Jawinski P et al. | β | 2025 | β |
| Genome-wide association study meta-analysis provides insights into the etiology of heart failure and its subtypes. | Henry A et al. | β | 2025 | β |
| Genome-Wide Insights Into the Genes and Pathways Shaping Human Foveal Development: Redefining the Genetic Landscape of Foveal Hypoplasia. | Hunt C et al. | β | 2025 | β |
| Genomics yields biological and phenotypic insights into bipolar disorder. | O'Connell KS et al. | β | 2025 | β |
| GWAS and multi-omics integrative analysis reveal novel loci and their molecular mechanisms for circulating fatty acids. | Sun Y et al. | β | 2025 | β |
| Heritable polygenic editing: the next frontier in genomic medicine? | Visscher PM et al. | β | 2025 | β |
| Improved genetic discovery and fine-mapping resolution through multivariate latent factor analysis of high-dimensional traits. | Zhou F et al. | β | 2025 | β |
| Investigating the common genetic basis between inflammatory bowel disease and metabolic syndrome through genomic structural equation modeling. | Shen P et al. | β | 2025 | β |
| Kidney multiome-based genetic scorecard reveals convergent coding and regulatory variants. | Liu H et al. | β | 2025 | β |
| Large-scale audiometric phenotyping identifies distinct genes and pathways involved in hearing loss subtypes. | Ahmed S et al. | β | 2025 | β |
| Leveraging functional annotations to map rare variants associated with Alzheimer disease with gruyere. | Das A et al. | β | 2025 | β |
| Leveraging pleiotropy for the improved treatment of psychiatric disorders. | Woodward DJ et al. | β | 2025 | β |
| Local genetic sex differences in quantitative traits. | Uffelmann E et al. | β | 2025 | β |
| Logica: A likelihood framework for cross-ancestry local genetic correlation estimation using summary statistics. | Gao B et al. | β | 2025 | β |
| Long-read RNA sequencing atlas of human microglia isoforms elucidates disease-associated genetic regulation of splicing. | Humphrey J et al. | β | 2025 | β |
| Mapping chromatin interactions at melanoma susceptibility loci uncovers distant cis-regulatory gene targets. | Thakur R et al. | β | 2025 | β |
| Multitrait GWAS of non-suicidal self-injury and the polygenetic effects on child psychopathology and brain structures. | Sun Y et al. | β | 2025 | β |
| Non-coding variation in dementias: mechanisms, insights, and challenges. | Rogers BB et al. | β | 2025 | β |
| Optimizing UK biobank cloud-based research analysis platform to fine-map coronary artery disease loci in whole genome sequencing data. | Sng LMF et al. | β | 2025 | β |
| Polygenic scores and their applications in kidney disease. | Khan A et al. | β | 2025 | β |
| Predicting RNA-seq coverage from DNA sequence as a unifying model of gene regulation. | Linder J et al. | β | 2025 | β |
| Prioritizing Parkinson's disease risk genes in genome-wide association loci. | Lange LM et al. | β | 2025 | β |
| Quantile-specific confounding: correction for subtle population stratification via quantile regression. | Wang C et al. | β | 2025 | β |
| Quantitative trait loci mapping of circulating metabolites in cerebrospinal fluid to uncover biological mechanisms involved in brain-related phenotypes. | Reus LM et al. | β | 2025 | β |
| Realizing the promise of genome-wide association studies for effector gene prediction. | Costanzo MC et al. | β | 2025 | β |
| Role of multi-omics in aquaculture genetics and breeding: current status and future perspective. | Yu X et al. | β | 2025 | β |
| The brief resilience scale: a genome-wide association study in the UK Biobank. | Cornelis MC et al. | β | 2025 | β |
| The Non-Coding Regulatory Variant rs2863002 at chr11p11.2 Increases Neuroblastoma Risk by Affecting HSD17B12 Expression and Lipid Metabolism. | Maiorino T et al. | β | 2025 | β |
| Towards improved fine-mapping of candidate causal variants. | Li Z et al. | β | 2025 | β |
| Trans-ancestry genome-wide study of depression identifies 697 associations implicating cell types and pharmacotherapies. | Major Depressive Disorder Working Group of the Psychiatric Genomics Consortium. Electronic address: andrew.mcintosh@ed.ac.uk et al. | β | 2025 | β |
| Unsupervised feature extraction using deep learning empowers discovery of genetic determinants of the electrocardiogram. | Sieliwonczyk E et al. | β | 2025 | β |
| Using omics data and genome editing methods to decipher GWAS loci associated with coronary artery disease. | Chignon A et al. | β | 2025 | β |
| Variant-specific priors clarify colocalisation analysis. | Pullin JM et al. | β | 2025 | β |
| Variant-to-function approaches for adipose tissue: Insights into cardiometabolic disorders. | Metz S et al. | β | 2025 | β |
| Widespread but moderate genetic overlap between circulating polyunsaturated fatty acids and brain disorders. | Xu H et al. | β | 2025 | β |
| A Bayesian fine-mapping model using a continuous global-local shrinkage prior with applications in prostate cancer analysis. | Li X et al. | β | 2024 | β |
| Accounting for genetic effect heterogeneity in fine-mapping and improving power to detect gene-environment interactions with SharePro. | Zhang W et al. | β | 2024 | β |
| A cell type-aware framework for nominating non-coding variants in Mendelian regulatory disorders. | Lee AS et al. | β | 2024 | β |
| Addressing Technical Pitfalls in Pursuit of Molecular Factors That Mediate Immunoglobulin Gene Regulation. | Engelbrecht E et al. | β | 2024 | β |
| Adjusting for genetic confounders in transcriptome-wide association studies improves discovery of risk genes of complex traits. | Zhao S et al. | β | 2024 | β |
| A genome-wide investigation into the underlying genetic architecture of personality traits and overlap with psychopathology. | Gupta P et al. | β | 2024 | β |
| A multi-cohort genome-wide association study in African ancestry individuals reveals risk loci for primary open-angle glaucoma. | Verma SS et al. | β | 2024 | β |
| Application of Genomic Data in Translational Medicine During the Big Data Era. | Zhang Y et al. | β | 2024 | β |
| Bayesian approach to assessing population differences in genetic risk of disease with application to prostate cancer. | Timmins IR et al. | β | 2024 | β |
| BEATRICE: Bayesian fine-mapping from summary data using deep variational inference. | Ghosal S et al. | β | 2024 | β |
| Benchmarking multi-ancestry prostate cancer polygenic risk scores in a real-world cohort. | Shah Y et al. | β | 2024 | β |
| Bidirectional Mendelian Randomization Highlights Causal Relationships Between Circulating INHBC and Multiple Cardiometabolic Diseases and Traits. | Loh NY et al. | β | 2024 | β |
| CoPheScan: phenome-wide association studies accounting for linkage disequilibrium. | Manipur I et al. | β | 2024 | β |
| Deciphering the impact of genomic variation on function. | IGVF Consortium | β | 2024 | β |
| Decoding polygenic diseases: advances in noncoding variant prioritization and validation. | Chin IM et al. | β | 2024 | β |
| Diversity and scale: Genetic architecture of 2068 traits in the VA Million Veteran Program. | Verma A et al. | β | 2024 | β |
| Fine-mapping across diverse ancestries drives the discovery of putative causal variants underlying human complex traits and diseases. | Yuan K et al. | β | 2024 | β |
| Fine mapping of candidate effector genes for heart rate. | RamΓrez J et al. | β | 2024 | β |
| From genetic associations to genes: methods, applications, and challenges. | Qi T et al. | β | 2024 | β |
| Funmap: integrating high-dimensional functional annotations to improve fine-mapping. | Li Y et al. | β | 2024 | β |
| Genetic and molecular architecture of complex traits. | Lappalainen T et al. | β | 2024 | β |
| Genetic architecture distinguishes tinnitus from hearing loss. | Clifford RE et al. | β | 2024 | β |
| Genetics of chronic respiratory disease. | Sayers I et al. | β | 2024 | β |
| Genetic, transcriptomic, histological, and biochemical analysis of progressive supranuclear palsy implicates glial activation and novel risk genes. | Farrell K et al. | β | 2024 | β |
| Genetic variation across and within individuals. | Yu Z et al. | β | 2024 | β |
| Genome-wide association analyses identify 95 risk loci and provide insights into the neurobiology of post-traumatic stress disorder. | Nievergelt CM et al. | β | 2024 | β |
| Genome-wide association analysis provides insights into the molecular etiology of dilated cardiomyopathy. | Zheng SL et al. | β | 2024 | β |
| Genome-wide association study implicates lipid pathway dysfunction in antipsychotic-induced weight gain: multi-ancestry validation. | Liao Y et al. | β | 2024 | β |
| Genomic dissection of the correlation between milk yield and various health traits using functional and evolutionary information about imputed sequence variants of 34,497 German Holstein cows. | Schneider H et al. | β | 2024 | β |
| Haplotype function score improves biological interpretation and cross-ancestry polygenic prediction of human complex traits. | Song W et al. | β | 2024 | β |
| Improved genetic discovery and fine-mapping resolution through multivariate latent factor analysis of high-dimensional traits | Zhou F et al. | β | 2024 | β |
| Improving fine-mapping by modeling infinitesimal effects. | Cui R et al. | β | 2024 | β |
| Improving polygenic risk prediction in admixed populations by explicitly modeling ancestral-differential effects via GAUDI. | Sun Q et al. | β | 2024 | β |
| Integration of expression QTLs with fine mapping via SuSiE. | Zhang X et al. | β | 2024 | β |
| Leveraging functional genomic annotations and genome coverage to improve polygenic prediction of complex traits within and between ancestries. | Zheng Z et al. | β | 2024 | β |
| Longitudinal machine learning uncouples healthy aging factors from chronic disease risks. | Cohen NM et al. | β | 2024 | β |
| MESuSiE enables scalable and powerful multi-ancestry fine-mapping of causal variants in genome-wide association studies. | Gao B et al. | β | 2024 | β |
| Meta-analysis of ACE inhibitor-induced angioedema identifies novel risk locus. | Mathey CM et al. | β | 2024 | β |
| Multimodal Omics Approaches to Aging and Age-Related Diseases. | Ji Q et al. | β | 2024 | β |
| MUSSEL: Enhanced Bayesian polygenic risk prediction leveraging information across multiple ancestry groups. | Jin J et al. | β | 2024 | β |
| Partitioned polygenic risk scores identify distinct types of metabolic dysfunction-associated steatotic liver disease. | Jamialahmadi O et al. | β | 2024 | β |
| Phenome-wide association study of population-differentiating genetic variants around gene <i>ACSL1</i>. | Yang S et al. | β | 2024 | β |
| Placental expression quantitative trait loci in an East Asian population. | Choi J et al. | β | 2024 | β |
| Population-specific putative causal variants shape quantitative traits. | Koyama S et al. | β | 2024 | β |
| Recent advances in polygenic scores: translation, equitability, methods and FAIR tools. | Xiang R et al. | β | 2024 | β |
| Review of pharmacogenetics of antiseizure medications: focusing on genetic variants of mechanistic targets. | Lin CH et al. | β | 2024 | β |
| Systematic prioritization of functional variants and effector genes underlying colorectal cancer risk. | Law PJ et al. | β | 2024 | β |
| The goldmine of GWAS summary statistics: a systematic review of methods and tools. | Kontou PI et al. | β | 2024 | β |
| The importance of functional genomics studies in precision rheumatology. | Piedade AP et al. | β | 2024 | β |
| The PRIMED Consortium: Reducing disparities in polygenic risk assessment. | Kullo IJ et al. | β | 2024 | β |
| Tissue-specific enhancer-gene maps from multimodal single-cell data identify causal disease alleles. | Sakaue S et al. | β | 2024 | β |
| Variants in tubule epithelial regulatory elements mediate most heritable differences in human kidney function. | Loeb GB et al. | β | 2024 | β |
| 150 risk variants for diverticular disease of intestine prioritize cell types and enable polygenic prediction of disease susceptibility. | Wu Y et al. | β | 2023 | β |
| Accurate and efficient estimation of local heritability using summary statistics and the linkage disequilibrium matrix. | Li H et al. | β | 2023 | β |
| Advances and Applications of Polygenic Scores for Coronary Artery Disease. | Patel AP et al. | β | 2023 | β |
| Ancestry-specific polygenic risk scores are risk enhancers for clinical cardiovascular disease assessments. | Busby GB et al. | β | 2023 | β |
| A new method for multiancestry polygenic prediction improves performance across diverse populations. | Zhang H et al. | β | 2023 | β |
| A new polygenic score for refractive error improves detection of children at risk of high myopia but not the prediction of those at risk of myopic macular degeneration. | Clark R et al. | β | 2023 | β |
| Artificial intelligence for dementia genetics and omics. | Bettencourt C et al. | β | 2023 | β |
| A unifying statistical framework to discover disease genes from GWASs. | McManus JNJ et al. | β | 2023 | β |
| A whole-genome reference panel of 14,393 individuals for East Asian populations accelerates discovery of rare functional variants. | Choi J et al. | β | 2023 | β |
| Biobank-scale methods and projections for sparse polygenic prediction from machine learning. | Raben TG et al. | β | 2023 | β |
| CARMA is a new Bayesian model for fine-mapping in genome-wide association meta-analyses. | Yang Z et al. | β | 2023 | β |
| cLD: Rare-variant linkage disequilibrium between genomic regions identifies novel genomic interactions. | Wang D et al. | β | 2023 | β |
| Colocalization of corneal resistance factor GWAS loci with GTEx e/sQTLs highlights plausible candidate causal genes for keratoconus postnatal corneal stroma weakening. | Jiang X et al. | β | 2023 | β |
| DNA language models are powerful predictors of genome-wide variant effects. | Benegas G et al. | β | 2023 | β |
| Estimating gene-level false discovery probability improves eQTL statistical fine-mapping precision. | Wang QS et al. | β | 2023 | β |
| Exploring the genetic basis of coronary artery disease using functional genomics. | LΓ³pez RodrΓguez M et al. | β | 2023 | β |
| Extremely sparse models of linkage disequilibrium in ancestrally diverse association studies. | Salehi Nowbandegani P et al. | β | 2023 | β |
| Finding Needles in the Haystack: Strategies for Uncovering Noncoding Regulatory Variants. | Chen Y et al. | β | 2023 | β |
| Genetic correlates of vitamin D-binding protein and 25-hydroxyvitamin D in neonatal dried blood spots. | AlbiΓ±ana C et al. | β | 2023 | β |
| Genetic insights into human cortical organization and development through genome-wide analyses of 2,347 neuroimaging phenotypes. | Warrier V et al. | β | 2023 | β |
| Genetic meta-analysis of levodopa induced dyskinesia in Parkinson's disease. | Martinez-Carrasco A et al. | β | 2023 | β |
| Genome-wide analysis identifies genetic effects on reproductive success and ongoing natural selection at the FADS locus. | Mathieson I et al. | β | 2023 | β |
| Genome-wide analysis of genetic pleiotropy and causal genes across three age-related ocular disorders. | Yao X et al. | β | 2023 | β |
| Genome-wide association studies and cross-population meta-analyses investigating short and long sleep duration. | Austin-Zimmerman I et al. | β | 2023 | β |
| Genome-Wide Association Study of Breast Density among Women of African Ancestry. | Verma SS et al. | β | 2023 | β |
| Genome-wide association study of thyroid-stimulating hormone highlights new genes, pathways and associations with thyroid disease. | Williams AT et al. | β | 2023 | β |
| Genome-wide enhancer-gene regulatory maps link causal variants to target genes underlying human cancer risk. | Ying P et al. | β | 2023 | β |
| Germline mechanisms of immunotherapy toxicities in the era of genome-wide association studies. | Gusev A | β | 2023 | β |
| Harnessing the potential of machine learning and artificial intelligence for dementia research. | Ranson JM et al. | β | 2023 | β |
| LDmat: efficiently queryable compression of linkage disequilibrium matrices. | Weiner RJ et al. | β | 2023 | β |
| Learning functional conservation between human and pig to decipher evolutionary mechanisms underlying gene expression and complex traits. | Li J et al. | β | 2023 | β |
| Leveraging base-pair mammalian constraint to understand genetic variation and human disease. | Sullivan PF et al. | β | 2023 | β |
| Leveraging information between multiple population groups and traits improves fine-mapping resolution. | Zhou F et al. | β | 2023 | β |
| Polygenic scores in cancer. | Yang X et al. | β | 2023 | β |
| Quantifying portable genetic effects and improving cross-ancestry genetic prediction with GWAS summary statistics. | Miao J et al. | β | 2023 | β |
| Single-cell genomics improves the discovery of risk variants and genes of atrial fibrillation. | Selewa A et al. | β | 2023 | β |
| SparsePro: An efficient fine-mapping method integrating summary statistics and functional annotations. | Zhang W et al. | β | 2023 | β |
| Transcriptome annotation of 17 porcine tissues using nanopore sequencing technology. | Li J et al. | β | 2023 | β |
| XMAP: Cross-population fine-mapping by leveraging genetic diversity and accounting for confounding bias. | Cai M et al. | β | 2023 | β |
| 3D genome organization links non-coding disease-associated variants to genes. | Orozco G et al. | β | 2022 | β |
| Advancing discovery of risk-altering variants for complex diseases by functionally informed fine-mapping. | Chen Y et al. | β | 2022 | β |
| Allelic imbalance of chromatin accessibility in cancer identifies candidate causal risk variants and their mechanisms. | Grishin D et al. | β | 2022 | β |
| Assessing polygenic risk score models for applications in populations with under-represented genomics data: an example of Vietnam. | Pham D et al. | β | 2022 | β |
| Beyond GWAS: from simple associations to functional insights. | Ishigaki K | β | 2022 | β |
| Combining SNP-to-gene linking strategies to identify disease genes and assess disease omnigenicity. | Gazal S et al. | β | 2022 | β |
| Comparative transcriptome in large-scale human and cattle populations. | Yao Y et al. | β | 2022 | β |
| Discovery and systematic characterization of risk variants and genes for coronary artery disease in over a million participants. | Aragam KG et al. | β | 2022 | β |
| echolocatoR: an automated end-to-end statistical and functional genomic fine-mapping pipeline. | Schilder BM et al. | β | 2022 | β |
| ezQTL: A Web Platform for Interactive Visualization and Colocalization of QTLs and GWAS Loci. | Zhang T et al. | β | 2022 | β |
| Fine-mapping of Parkinson's disease susceptibility loci identifies putative causal variants. | Schilder BM et al. | β | 2022 | β |
| Fine mapping with epigenetic information and 3D structure. | Orozco G | β | 2022 | β |
| Functional Characterization of Genetic Variant Effects on Expression. | Flynn ED et al. | β | 2022 | β |
| Gene-based polygenic risk scores analysis of alcohol use disorder in African Americans. | Lai D et al. | β | 2022 | β |
| Genome-wide association analysis and replication in 810,625 individuals with varicose veins. | Ahmed WU et al. | β | 2022 | β |
| Genome-wide identification of the shared genetic basis of cannabis and cigarette smoking and schizophrenia implicates NCAM1 and neuronal abnormality. | Song W et al. | β | 2022 | β |
| Genome-wide meta-analysis of insomnia prioritizes genes associated with metabolic and psychiatric pathways. | Watanabe K et al. | β | 2022 | β |
| Improving GWAS discovery and genomic prediction accuracy in biobank data. | Orliac EJ et al. | β | 2022 | β |
| Leveraging fine-mapping and multipopulation training data to improve cross-population polygenic risk scores. | Weissbrod O et al. | β | 2022 | β |
| Massively parallel reporter assays and variant scoring identified functional variants and target genes for melanoma loci and highlighted cell-type specificity. | Long E et al. | β | 2022 | β |
| Meta-analysis fine-mapping is often miscalibrated at single-variant resolution. | Kanai M et al. | β | 2022 | β |
| Methods for statistical fine-mapping and their applications to auto-immune diseases. | Wang QS et al. | β | 2022 | β |
| Multi-omic insights into Parkinson's Disease: From genetic associations to functional mechanisms. | Schilder BM et al. | β | 2022 | β |
| Open problems in human trait genetics. | Brandes N et al. | β | 2022 | β |
| Partitioning gene-level contributions to complex-trait heritability by allele frequency identifies disease-relevant genes. | Burch KS et al. | β | 2022 | β |
| SNP-to-gene linking strategies reveal contributions of enhancer-related and candidate master-regulator genes to autoimmune disease. | Dey KK et al. | β | 2022 | β |
| Statistical learning for sparser fine-mapped polygenic models: The prediction of LDL-cholesterol. | Maj C et al. | β | 2022 | β |
| The conservation of human functional variants and their effects across livestock species. | Zhao R et al. | β | 2022 | β |
| The missing link between genetic association and regulatory function. | Connally NJ et al. | β | 2022 | β |
| The whole blood transcriptional regulation landscape in 465 COVID-19 infected samples from Japan COVID-19 Task Force. | Wang QS et al. | β | 2022 | β |
| Three assays for in-solution enrichment of ancient human DNA at more than a million SNPs. | Rohland N et al. | β | 2022 | β |
| Transcription factor regulation of eQTL activity across individuals and tissues. | Flynn ED et al. | β | 2022 | β |
| TSABL: Trait Specific Annotation Based Locus predictor. | Lorenz K et al. | β | 2022 | β |
| A compendium of uniformly processed human gene expression and splicing quantitative trait loci. | Kerimov N et al. | β | 2021 | β |
| A functional genomics pipeline identifies pleiotropy and cross-tissue effects within obesity-associated GWAS loci. | Joslin AC et al. | β | 2021 | β |
| Dysregulation of mitochondrial and proteolysosomal genes in Parkinson's disease myeloid cells. | Navarro E et al. | β | 2021 | β |
| Effective gene expression prediction from sequence by integrating long-range interactions. | Avsec Ε½ et al. | β | 2021 | β |
| From variant to function in human disease genetics. | Lappalainen T et al. | β | 2021 | β |
| Leveraging supervised learning for functionallyΒ informed fine-mapping of cis-eQTLs identifies an additional 20,913 putative causal eQTLs. | Wang QS et al. | β | 2021 | β |
| Machine learning enables new insights into genetic contributions to liver fat accumulation. | Haas ME et al. | β | 2021 | β |
| Maintenance of Complex Trait Variation: Classic Theory and Modern Data. | Koch EM et al. | β | 2021 | β |
| Monogenic and Polygenic Models of Coronary Artery Disease. | Muse ED et al. | β | 2021 | β |
| Predicting Risk of Hypertension Among Childhood Cancer Survivors: A Polygenic Score to the Rescue? | Agrawal S et al. | β | 2021 | β |
| Quantitative Human Paleogenetics: What can Ancient DNA Tell us About Complex Trait Evolution? | Irving-Pease EK et al. | β | 2021 | β |
| Recalling the pathology of Parkinson's disease; lacking exact figure of prevalence and genetic evidence in Asia with an alarming outcome: A time to step-up. | Mahmood A et al. | β | 2021 | β |
| The distribution of common-variant effect sizes. | O'Connor LJ | β | 2021 | β |
| The flashfm approach for fine-mapping multiple quantitative traits. | HernΓ‘ndez N et al. | β | 2021 | β |
| Transcriptional-regulatory convergence across functional MDD risk variants identified by massively parallel reporter assays. | Mulvey B et al. | β | 2021 | β |
| Fine-mapping genetic associations. | Hutchinson A et al. | β | 2020 | β |
| Genetics of Parkinson's disease: An introspection of its journey towards precision medicine. | Bandres-Ciga S et al. | β | 2020 | β |
| Improving the informativeness of Mendelian disease-derived pathogenicity scores for common disease. | Kim SS et al. | β | 2020 | β |